Tiger Paw Tiger Paw
The surgical staple device, Tiger Paw, has been recalled and the FDA has warned the public of serious heart injuries that may occur after use.
Check your eligibility for compensation below before time runs out.
Those who have been affected by any of the following injuries after receiving surgical staples may be entitled to financial compensation:
Tiger Paw System II is a medical staple device that was approved by the FDA in 2010 and is manufactured by Maquet Medical Systems. The device is specifically designed to close the left atrial appendage (LAA) and prevent strokes from occurring in atrial fibrillation patients.
In April 2015, the FDA issued a recall on the Tiger Paw System II device after several individuals reported adverse cardiac complications such as tearing.
The FDA’s Class I Recall of the Tiger Paw System II device encompasses over 4,000 medical devices that were distributed to various medical facilities from April 2013 to March 2015. So far, Maquet Medical Systems has received a total of 51 adverse event reports and one report of death linked to its Tiger Paw System II device.
If you or a loved one has experienced an injury after receiving surgical staples such as atrial wall tear, incomplete closure, and other heart tissue tears we urge you to at today. You may be entitled to compensation for injury related medical expenses and pain and suffering. Request your free case review with an attorney today to begin to seek justice from the manufacturer.
